Geovax reports third quarter 2024 financial results and provides business update

Progress in geo-cm04s1 barda/project nextgen phase 2b trial; multiple data readouts of existing covid-19 vaccine phase 2 trials expected during fourth quarter 2024

GOVX Ratings Summary

GOVX Quant Ranking